Clinical Trials on SARS-CoV2 Infection

Total 61411 results

University Hospital, Antwerp

Suspended

Microbiome Therapy in Covid-19 Primary Care Support (MiCel)

Corona Virus Infection | SARS-CoV Infection

Belgium
University Hospital, Geneva
University of Geneva, Switzerland

Completed

Understanding COVID-19

SARS-CoV-2 Viral Kinetics and Host Immune Responses

Switzerland
University Hospital, Geneva

Terminated

Preventing COVID-19 Complications With Low- and High-dose Anticoagulation (COVID-HEP)

COVID | Sars-CoV2

Switzerland
Hospital Italiano de Buenos Aires

Completed

Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia (PLASM-AR)

COVID-19 | SARS-CoV-2 | SARS Virus

Argentina
Technical University of Munich
Charite University, Berlin, Germany

Recruiting

Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis (ME/CFS) Registry and Biobank, COVID-19, SARS-CoV-2 (MECFS-R)

Fatigue Syndrome, Chronic | SARS CoV 2 Infection | ME/CFS | Epstein-Barr Virus

Germany
National Jewish Health

Recruiting

COVID-19 Vaccine Response in Chronic Respiratory Conditions

SARS-CoV Infection

United States
University Hospitals Cleveland Medical Center
Northwestern University

Withdrawn

Tele-health Enabled Clinical Trial for COVID-19

SARS-CoV Infection

United States
University Hospital of Ferrara

Unknown

Electrocardiogram Analysis in COVID-19 Patients (ELCOVID)

SARS-CoV Infection

Italy
Azienda Ospedaliero-Universitaria di Parma
University of Parma

Withdrawn

Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19 (OsCOVID19)

Covid-19 | SARS-CoV 2 | Corona Virus Infection

Italy, France
Arcturus Therapeutics, Inc.

Recruiting

A Trial Evaluating the Safety and Immunogenicity of 3 COVID-19 SARS-CoV-2 RNA Vaccines in Healthy Adults

COVID-19 | Corona Virus Infection | SARS-CoV-2 Infection

United States, Singapore
IRCCS San Raffaele

Active, not recruiting

Establishment of a Biological Biobank of Subjects Vaccinated Against SARS-CoV-2 Infection (COVID-19)

Coronavirus Infections

Italy
University of North Carolina, Chapel Hill
Colgate Palmolive

Terminated

Antiviral Efficacy and Acceptability of Mouth Rinses for Inactivation of COVID-19 (COL)

Coronavirus Infection | COVID19 | SARS CoV-2 Infection

United States
Portsmouth Hospitals NHS Trust

Completed

A Feasibility Study Using the CoronaCheck Device to Identify Incident Cases of SARS CoV-2 Covid-19

SARS-CoV Infection

United Kingdom
Centre Hospitalier Universitaire de la Réunion

Active, not recruiting

HDL Target of CoViD19 ? Analysis on the Caregivers of the Reunion University Hospital (H-Cov-Run)

SARS-CoV Infection

France
Universitair Ziekenhuis Brussel

Active, not recruiting

SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel Following mRNA COVID-19 Vaccination

SARS-CoV Infection

Belgium
UnitedHealth Group
Mayo Clinic; Bill and Melinda Gates Foundation; PATH

Completed

A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research

SARS-CoV Infection

United States
Neuromed IRCCS

Withdrawn

Efficacy and Safety of Ozonised Oil (HOO) in COVID-19 Patients (HOO-COVID)

SARS-CoV Infection
AB Biotics, SA
Hospital General Dr. Manuel Gea González; Innovacion y Desarrollo de Estrategias... and other collaborators

Completed

Efficacy of L. Plantarum and P. Acidilactici in Adults With SARS-CoV-2 and COVID-19

SARS-CoV Infection

Mexico
Lahore General Hospital

Unknown

Remdesivir in COVID-19 Lahore General Hospital (RC19LGH)

SARS-CoV Infection

Pakistan
University of Chicago

Recruiting

A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 Infection (COVID-19)

COVID-19

United States
Sinocelltech Ltd.

Not yet recruiting

A Study to Evaluate the Immunogenicity and Safety of A Recombinant Protein COVID-19 Vaccine as Booster Vaccines

COVID-19 | SARS-CoV-2 Infection
Direction Centrale du Service de Santé des Armées

Recruiting

COVID-19: Early Detection of Worsening by Voice and Respiratory Pattern Characteristics (COVOICE)

COVID-19 | Sars-CoV-2 Infection

France
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

CORONABED.BOT -COVID-19: an Automation Project Using Artificial Intelligence for Early Diagnosis of Clinical Evolution From SARS-CoV-2" (CORONABED_BOT)

SARS-CoV-1 Infection

Italy
Bioxytran Inc.

Not yet recruiting

To Evaluate the Safety, Efficacy,and Pharmacokinetics of Orally Administered Prolectin-M

COVID-19 | SARS CoV 2 Infection
Sinocelltech Ltd.

Not yet recruiting

A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine as a Booster Dose in Population Aged 12-17 Years

COVID-19 | SARS-CoV-2 Infection
Centre Hospitalier Régional d'Orléans

Recruiting

Neutralizing Power of Anti-SARS-CoV-2 (Anti-COVID-19) Serum Antibodies (PNAS)

COVID-19 | SARS CoV 2 Infection

France
Sinocelltech Ltd.

Not yet recruiting

A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C in Population Aged ≥18 Years and Previously Fully Vaccinated With COVID-19 Vaccine

COVID-19 | SARS-CoV-2 Infection
Sinocelltech Ltd.

Recruiting

The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With mRNA COVID-19 Vaccine.

COVID-19 | SARS-CoV-2 Infection

United Arab Emirates
WestVac Biopharma Co., Ltd.

Active, not recruiting

Safety and Immunogenicity of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) as a Booster

COVID-19 | SARS-CoV-2 Infection

Mexico
Novavax

Completed

Phase 3 Boosting Study for the SARS-CoV-2 rS Variant Vaccines (COVID-19)

COVID-19 | SARS CoV 2 Infection

Australia
Atea Pharmaceuticals, Inc.

Active, not recruiting

SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19

COVID-19 | SARS CoV 2 Infection

United States, Argentina, Brazil, Canada, Germany, India, Japan, Latvia, Mexico, Netherlands, Pakistan, Philippines, Romania, South Africa, Spain, Sweden, Tunisia, Turkey, United Kingdom
Sinocelltech Ltd.

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of SCTV01E (a COVID-19 Vaccine) in Population Aged ≥18 Years

COVID-19 | SARS-CoV-2 Infection

China
University of Cologne
Boehringer Ingelheim; ZKS Köln

Completed

SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Infusion

SARS-CoV-2 Infection

Germany
BioNTech SE
Pfizer

Active, not recruiting

A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals

COVID-19 | SARS-CoV-2 Infection

United States
Health Institutes of Turkey

Completed

Phase 3 Booster Vaccination Against COVID-19

COVID-19 | Sars-CoV-2 Infection

Turkey
Speransa Therapeutics

Terminated

A Study Assessing the Safety, Tolerability, Immunogenicity of COVID-19 Vaccine Candidate PRIME-2-CoV_Beta, Orf Virus Expressing SARS-CoV_2 Spike and Nucleocapsid Proteins

SARS-CoV-2 Infection

United States, Germany
Serap Yavuz
MDX Klinik Araştırma Egitim ve Danismanlik Ltd. Sti.

Active, not recruiting

Evaluation of the Efficacy and Safety of Molnupiravir Treatment in Mild/Moderate Covid-19 Patients.

COVID-19 | SARS-CoV-2 Infection

Turkey
Pfizer

Completed

A Study to Understand the Effect and Safety of the Study Medicine PF-07817883 in Adults Who Have Symptoms of COVID-19 But Are Not Hospitalized

SARS-CoV-2 Infection

United States
Health Institutes of Turkey

Completed

Booster Vaccination Against COVID-19

COVID-19 | Sars-CoV-2 Infection

Turkey
ACM Biolabs

Completed

Booster Dose Study to Assess the Safety and Immunogenicity of ACM-001 Administered Intramuscularly or Intranasally.

SARS-CoV-2 Infection

Australia
RSV Therapeutics LLC

Completed

A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19

SARS-CoV-2 Infection

Russian Federation
University of Minnesota

Completed

Evaluation of Point-of-Care (EPOC) for COVID-19 ((EPOC))

COVID-19 | SARS CoV 2 Infection

United States
Prisma Health-Upstate

Completed

COVID-19 on Placental Gene Expression and Pathology (PROSPER)

COVID-19 | SARS-CoV-2 Infection

United States
Sinocelltech Ltd.

Active, not recruiting

A Study to Evaluate the Immunogenicity and Safety of Two Recombinant Protein COVID-19 Vaccines in Population Aged ≥18 Years as Booster Vaccines

COVID-19 | SARS-CoV-2 Infection

United Arab Emirates
BioNTech SE
Pfizer

Completed

Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals

COVID-19 | SARS-CoV-2 Infection

United States, Germany, Turkey, South Africa, Argentina, Brazil
EDP Biotech
Paragon Rx Clinical, Inc.; iCura Diagnostics, LLC

Completed

COVID-19 iCura SARS-CoV-2 Ag OTC: Clinical Evaluation

COVID-19 | SARS-CoV-2 Infection

United States
Institute of Health Information and Statistics...
Institute for Clinical and Experimental Medicine; University Hospital Olomouc; The Institute of Molecular and Translational Medicine, Czech Republic and other collaborators

Completed

COVID-19: SARS-CoV-2-CZ-PREVAL-II Study

COVID-19 | SARS-CoV-2 Infection

Czechia
Alder Hey Children's NHS Foundation Trust

Completed

The LAVA (Lateral Flow Antigen Validation and Applicability) 2 Study for COVID-19 (LAVA2)

SARS-CoV-2 Infection

United Kingdom
Valneva Austria GmbH

Withdrawn

COVID-19 Paediatric VLA2001-321 Study

SARS-CoV-2 Infection
Nanogen Pharmaceutical Biotechnology Joint Stock...

Active, not recruiting

Study to Evaluate the Safety, Immunogenicity, and Efficacy of Nanocovax Vaccine Against COVID-19

COVID-19 | SARS-CoV-2 Infection

Vietnam

Clinical Trials on SARS-CoV2 Infection

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations